The first private incubator of microbiome biotech companies
At Nexbiome Therapeutics, we define the microbiome as an ecosystem of microorganisms, the composition of which predisposes to health or to illness. Consequently, we are convinced that the microbiome represents the reservoir of therapeutic solutions for the future of human health.
Our mission is to identify the best research projects and turn them into biotech companies that will bring innovative health solutions to the market. Our ambition is to contribute to the emergence of global champions in every therapeutic segment for which health through the microbiome makes sense.
|Project Code||Pathology||Techno||Discovery||Preclinical||Phase 1||Phase 2||Phase 3||Regulatory Approval|
|BGA-1601||Ulcerative colitis||Recombinant LBP|